Lia Luus

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Venues

Nature biomedical engineering

Science translational medicine

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Punit Upadhyaya, Julia Kristensson, Johanna Lahdenranta, Elizabeth Repash, Jun Ma, Jessica Kublin, Gemma E Mudd, Lia Luus, Phil Jeffrey, Kristen Hurov, Kevin McDonnell, Nicholas Keen
Discovery and Optimization of a Synthetic Class of Nectin-4-Targeted CD137 Agonists for Immuno-oncology. Journal of medicinal chemistry 65 (14) (2022)
Eric M Tam, Ross B Fulton, James F Sampson, Marco Muda, Adam Camblin, Jennifer Richards, Alexander Koshkaryev, Jian Tang, Vinodh Kurella, Yang Jiao, Lihui Xu, Kathy Zhang, Neeraj Kohli, Lia Luus, Elizabeth Hutto, Sandeep Kumar, James Lulo, Violette Paragas, Christina S F Wong, James J Suchy, Stephanie Grabow, Anne-Sophie Dugast, Hong Zhang, Fabien Depis, Sonia Feau, Aniela Jakubowski, Wenlian Qiao, Galina Craig, Maja Razlog, James Qiu, Yu Zhou, James D Marks, Michael Croft, Daryl C Drummond, Andreas Raue
Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity. Science translational medicine 11 (512) (2020)
Walid S Kamoun, Dmitri B Kirpotin, Zhaohua Richard Huang, Suresh K Tipparaju, Charles O Noble, Mark E Hayes, Lia Luus, Alexander Koshkaryev, Jaeyeon Kim, Ken Olivier, Tad Kornaga, Shinji Oyama, Vasileios Askoxylakis, Christine Pien, Geoffrey Kuesters, Nancy Dumont, Alexey A Lugovskoy, Sarah A Schihl, John H Wilton, Melissa L Geddie, James Suchy, Stephanie Grabow, Neeraj Kohli, C Patrick Reynolds, Rachel Blaydes, Yu Zhou, Andrew J Sawyer, James D Marks, Daryl C Drummond
Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models. Nature biomedical engineering 3 (4) (2019)

Lia Luus.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lia Luus